Olipudase alfa enzyme replacement therapy reverses interstitial lung disease in adults with acid sphingomyelinase deficiency: Long-term pulmonary outcomes of the ASCEND trial
- Resource Type
- Abstract
- Source
- In
Molecular Genetics and Metabolism February 2024 141(2) - Subject
- Language
- ISSN
- 1096-7192